Market Place
Sourcing Support
FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea
Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of
Top Pharma Companies & Drugs in 2021: Covid vaccines, pills cause churn in list
Every year, the list of top pharmaceutical products and companies by sales sees some churn. But the
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
2017 – Recap of Warning Letters, Import Alerts and Non-Compliances
Data
integrity continued to be a hot topic in the pharmaceutical industry through
2017. According to
Amsterdam to host EMA; China pulls Skype out of app stores
This week in Phispers, we tell you how Amsterdam became EU’s choice for hosting the EMA. As Bi
Axovant’s hyped Alzheimer’s drug fails trial as Pfizer emulates Axovant; Amneal and Impax in merger talks
This week in Phispers, we bring you news about intepirdine, Axovant’s experimental drug for Al
Pfizer sues J&J; Generics under pressure; China’s Fosun resurrects deal to buyout India’s Gland
This week, Phispers brings you news on how a federal judge in the US revoked ‘pharma bro&rsquo
FDA to share full inspection reports with EU; Difficult week for Teva, J&J, Mylan
This week, Phispers brings you the latest from the world of biosimilars, with Samsung Bioepis tying
Dr. Reddy’s fails EU inspection; Trump disbands business councils after Merck CEO and others quit it over intolerance
This week, Phispers brings you the high-pitched drama from President Trump’s American Manufact
Trump tells FDA to fund itself fully through industry fees; Astra’s CEO dumps Teva offer
This
week, Phispers brings you lots of regulatory news from the US, where the Trump
administration h
